GUTLINK4KIDS Intervention
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-5
SponsorUniversity of Reading
About this trial
This study aims to investigate the chronic effects of prebiotic consumption on cognitive, behavioural and gut microbiome outcomes in children aged 3-5 years.
Eligibility criteria
Qualifiers
Parents (18 years and over) of generally healthy children aged 3-5-years-old (36-71 months) with lower dietary fibre intake than the recommended daily amount (10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).
Disqualifiers
Children with a significant acute or chronic co-existing illness (including inflammatory bowel disease, functional gastrointestinal disorders, coeliac disease etc, neurodevelopmental, immunological, psychiatric, or metabolic disorders.
Children who have taken any pre/probiotic supplements or antibiotic treatment within the 4 weeks prior to enrolment.
Children with food allergies and intolerances
Trial design
Treatments tested in this trial
- Prebiotic powder
- Placebo
Treatment groups
106 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Reading
Lead sponsor
Beneo GmbH
Collaborator
Source ClinicalTrials.gov